News | October 07, 2010

Blood Pressure Pills More Effective When Taken at Night

October 7, 2010 - Taking medication at night instead of in the morning significantly increases efficacy in keeping blood pressure within a healthy range, according to a new study in Chronobiology International. Additionally, taking medication at night offers extra protection against heart attacks, strokes and other types of cardiovascular diseases.

Two articles in Chronobiology International, the international journal on how biological rhythms affect the systems of living things, cover the results of the MAPEC study.

Over the five-year study, the group of patients who took at least one of their medications at night experienced just one-third of the number of cardiovascular disease (CVD) episodes experienced by the group of patients who took all their medications in the morning.

"This study proves that the time of day when patients take their high blood pressure medications can make a huge difference due to the effect of the body's circadian rhythms on the actions of medications and because of the importance of preserving the normal day-night pattern of blood pressure in hypertension," said professor Ramón C. Hermida, Ph.D., director of bioengineering and chronobiology labs at the University of Vigo in Spain and lead investigator of the MAPEC Study. "Conventional treatment typically advises taking blood pressure medications in the morning. The MAPEC study shows that conventional treatment is not the most effective way to help patients with high blood pressure.”

Based on around-the-clock ambulatory blood pressure monitoring, the study found that taking at least one blood pressure medication at bedtime was best at normalizing sleep-time blood pressure. This is known to be the most sensitive predictor of a patient's five-year risk of CVD mortality. In addition, the study shows that taking medication at night is the best way to control daytime BP levels.

"Historically, medical professionals have operated on the assumption that sleep-time blood pressure levels will drop by 10 to 20 percent from daytime levels. However, for many patients – called nondippers – this doesn't happen and sleep-time therefore becomes a high risk period," said Francesco Portaluppi, M.D., of the Hypertension Center at the University Hospital of Ferrara in Italy and lead author of the perspectives article on the MAPEC study. "This study was the first to conclusively find that the time of day when medications are ingested not only affects efficacy but also CVD risk and these findings must fundamentally change the way patients are treated worldwide."

"Our body clocks are extremely powerful biological tools and this study offers insight and hard facts on how we can harness that power to help millions of people stay healthier and safer by ensuring that their blood pressure medications are taken as effectively as possible," said Michael Smolensky, editor of Chronobiology International.

More than 70 million people in the United States have hypertension.

For more information: www.informahealthcare.com


Related Content

News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Subscribe Now